News
Cellectis, Primera partner for mitochondrial disease gene therapies
Cellectis has entered into a strategic collaboration agreement with Primera Therapeutics to develop a gene editing platform to treat mitochondrial diseases.
Primera Therapeutics is launched by...
News
BDR Pharma launches first generic apalutamide to treat prostate...
BDR Pharmaceutical has launched the first generic apalutamide in India to treat both metastatic castration sensitive prostate cancer as well as non-metastatic castration resistant prostate...
Drug Research
Alligator and Orion expand immuno-oncology research alliance
Alligator Bioscience has expanded its research collaboration and license agreement with Orion Corp., a global pharmaceutical company based in Finland, to discover and develop new...
News
Polysciences Announces New Bioprocessing Brand, Kyfora Bio
Polysciences, Inc., a Pennsylvania-based manufacturer of specialty chemicals for research, IVD and medical device applications, plans to create a new brand, Kyfora Bio, representing its...
Drug Research
A Brand-New Medication For Dystonia Treatment Is Underway
Thousands of musicians now have hope after substantial progress was made in the search for a dystonia cure by a research team in Korea.
1–3% of...
Drug Research
First Time, Treatment For Acute ASPS Given The Go-Ahead
Atezolizumab (Tecentriq), a therapy for advanced alveolar soft tissue sarcoma (ASPS), has received FDA approval for the first time for adults and children two years...
Drug Research
FDA Drug Nods Dip To 37 In 2022 From...
The FDA recorded only 37 new drug approvals in 2022, down from an annual average of 51 since 2017. After having to retract its contentious...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.